Many researchers interpreted this as an encouragement by the FDA of the use of adaptive design methods or Bayesian approaches in pharmaceutical clinical development priligy premature ejaculation pills Development of an ototoxicity model in the adult CBA CaJ mouse and determination of a golden window of corticosteroid intervention for otoprotection